RxDoctor Payments Data

Jamie Bosnjak, APRN

Psychiatric/Mental Health · Maryville, TNNPI 1538942446

Payments from drug & device makers

$3,321in general payments, 2019–2025

Across 236 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$592
  • Lundbeck LLC$496
  • Otsuka America Pharmaceutical, Inc.$481
  • Johnson & Johnson$398
  • Corium, LLC$275
  • Neurocrine Biosciences, Inc.$199
  • plus $880 from 9 others

What the payments were for

  • Food & beverage$3,321100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,321 in reported general payments places this provider in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$2,349
Medicare patients
17
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$97,179
Abilify MaintenaAripiprazole31$81,715
CaplytaLumateperone Tosylate44$75,546
VraylarCariprazine Hcl39$56,215
RexultiBrexpiprazole12$18,979
TrintellixVortioxetine Hydrobromide21$11,194
QelbreeViloxazine Hcl12$8,921
Oxcarbazepine90$5,252
Buspirone Hcl118$1,918
Hydroxyzine Hcl71$1,748
Lurasidone Hcl12$1,453
Quetiapine Fumarate84$1,337
Aripiprazole30$857
Atomoxetine Hcl11$660
Desmopressin Acetate11$657

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$481$100,69543 claims
Neurocrine Biosciences, Inc.Ingrezza$199$97,17912 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$141$75,54644 claims
AbbVieVraylar$164$56,21539 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$51$11,19421 claims
Supernus Pharmaceuticals, Inc.Qelbree$592$8,92112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →